Your session is about to expire
← Back to Search
Exercise and Physical Activity Programs for Prostate Cancer Recovery (CONTROL4LIFE Trial)
N/A
Recruiting
Led By Nathan Hoy, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be scheduled for a prostatectomy surgery (any surgical approach)
Have a diagnosis of prostate cancer (stage I to IV)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how prostate cancer surgery affects continence, sexual function and overall health outcomes. Participants will get resources from Alberta Health Services and be evaluated on physical activity, fitness and quality of life.
Who is the study for?
Men who speak English, have prostate cancer (stages I-IV), and are set for prostatectomy surgery can join. They must be able to do mild exercise as confirmed by a questionnaire, be 18 or older, and willing to commit to a 12-week intervention if choosing the optional exercise component. Men with conditions affecting continence or contraindications to exercise, recent changes in incontinence meds, or no internet/smart device access cannot participate.
What is being tested?
The CONTROL 4 LIFE study is testing how general exercises and physical activity counseling along with pelvic floor exercises affect recovery of continence, sexual function, fitness and overall health after prostate cancer surgery. Participants will also receive Alberta Health Services resources on pre- and post-surgery care.
What are the potential side effects?
Since this trial involves non-drug interventions like exercise programs and counseling rather than medications, side effects may include typical risks associated with physical activity such as muscle soreness or strain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for surgery to remove my prostate.
Select...
I have been diagnosed with prostate cancer at any stage.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Completion Rate
Secondary study objectives
24-hour pad test
36-Item Short Form Survey
Adherence rate
+16 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment2 Interventions
Pelvic floor exercise program and general exercise programming
Group II: ControlActive Control2 Interventions
Pelvic floor exercises and standard care (physical activity counseling)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
General exercise
2020
N/A
~210
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
942 Previous Clinical Trials
434,303 Total Patients Enrolled
4 Trials studying Metabolic Diseases
621 Patients Enrolled for Metabolic Diseases
Nathan Hoy, MDPrincipal InvestigatorUniversity of Alberta
Howard Evans, MDPrincipal InvestigatorUniversity of Alberta
1 Previous Clinical Trials
Margaret McNeelyPrincipal InvestigatorUniversity of Alberta
2 Previous Clinical Trials
53 Total Patients Enrolled